OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹8.67 Cr | ₹17 Cr | ₹11 Cr | ₹6.33 Cr | ₹8.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹8.67 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹6.33 Cr |
| Mar2021 | ₹8.67 Cr |
How is Cash Flow from Financing Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.67 Cr | -49.41 | |
| Mar2024 | ₹17 Cr | 52.64 | |
| Mar2023 | ₹11 Cr | 77.26 | |
| Mar2022 | ₹6.33 Cr | -26.94 | |
| Mar2021 | ₹8.67 Cr | - | |
Compare Cash Flow from Financing Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹204.3 Cr | -0.9% | 17.6% | -40.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0.9% |
17.6% |
-40.4% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses